Physician
Hellen Rurangirwa MD PA Pediatric Clinic
Hellen Rurangirwa MD PA Pediatric Clinic was paid $4.62M by Medicaid between Oct 2020 and Dec 2024, across 60 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoHELLEN RURANGIRWA MD PA PEDIATRIC CLINIC
BROWNSVILLE, TX 78520
BROWNSVILLE, TX 78520
33aNPI1144850520assigned 01/24/2020
33bProvider typePediatrics Physician
28Total paid$4.62M
24GClaims229,247
24DCodes billed60
24AFirst – last monthOct 2020 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#92 of 1,136
Median peer was paid$329K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,612 | $35K | |
| 2021 | 28,086 | $642K | |
| 2022 | 49,125 | $966K | |
| 2023 | 78,102 | $1.55M | |
| 2024incomplete | 72,322 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 27,340 | 21,065 | $952K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 17% | 23,398 | 18,985 | $793K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 9,512 | 8,240 | $470K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 9.9% | 44,448 | 18,482 | $456K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.3% | 4,129 | 3,778 | $290K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.8% | 3,709 | 3,516 | $269K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.1% | 17,960 | 15,169 | $190K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.7% | 15,875 | 6,210 | $173K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.9% | 1,791 | 1,727 | $133K |
| 99429 | 2.4% | 3,597 | 3,489 | $112K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.3% | 1,900 | 1,869 | $106K |
| S8301 | Infection control supplies, not otherwise specified | 1.8% | 8,814 | 7,376 | $85K |
48 more codes
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.6% | 6,449 | $76K |
| 87807 | 1.5% | 8,006 | $67K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 858 | $66K |
| 99381 | 1.3% | 818 | $62K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 9,607 | $48K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,999 | $43K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,085 | $39K |
| 99383 | <1% | 451 | $37K | |
| 99382 | <1% | 428 | $35K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 664 | $23K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,018 | $14K |
| 90461 | <1% | 4,649 | $12K | |
| 99384 | <1% | 111 | $10K | |
| 86580 | <1% | 1,343 | $9K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 114 | $9K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 583 | $7K |
| 99051 | <1% | 1,374 | $6K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,964 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 228 | $5K |
| 81002 | <1% | 1,522 | $3K | |
| 69210 | <1% | 75 | $2K | |
| 96160 | <1% | 1,193 | $2K | |
| 17250 | <1% | 29 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 45 | $2K |
| 97169 | <1% | 45 | $1K | |
| 17000 | <1% | 12 | $536.16 | |
| CP002 | <1% | 41 | $392.00 | |
| 83655 | <1% | 34 | $254.24 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 160 | $5.84 |
| 90686 | <1% | 1,433 | $1.51 | |
| 90677 | <1% | 1,285 | $1.35 | |
| 90651 | <1% | 84 | $0.05 | |
| 90621 | <1% | 43 | $0.04 | |
| 90672 | <1% | 81 | $0.03 | |
| 90620 | <1% | 13 | $0.03 | |
| 90381 | <1% | 19 | $0.02 | |
| 90670 | <1% | 1,701 | $0.01 | |
| 90710 | 0% | 1,042 | $0.00 | |
| 90700 | 0% | 317 | $0.00 | |
| 90633 | 0% | 1,216 | $0.00 | |
| 90734 | 0% | 87 | $0.00 | |
| 90715 | 0% | 12 | $0.00 | |
| 90648 | 0% | 45 | $0.00 | |
| 90647 | 0% | 1,886 | $0.00 | |
| 90698 | 0% | 770 | $0.00 | |
| 90723 | 0% | 1,445 | $0.00 | |
| 90680 | 0% | 2,169 | $0.00 | |
| 90696 | 0% | 221 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRURANGIRWA, HELLEN (PRESIDENT)